166 related articles for article (PubMed ID: 29334279)
1. Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles.
Thakkar SG; Xu H; Li X; Cui Z
J Drug Target; 2018; 26(5-6):474-480. PubMed ID: 29334279
[TBL] [Abstract][Full Text] [Related]
2. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles.
Li X; Aldayel AM; Cui Z
J Control Release; 2014 Jan; 173():148-57. PubMed ID: 24188959
[TBL] [Abstract][Full Text] [Related]
3. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.
Ruwona TB; Xu H; Li X; Taylor AN; Shi YC; Cui Z
Vaccine; 2016 Jun; 34(27):3059-3067. PubMed ID: 27155490
[TBL] [Abstract][Full Text] [Related]
4. Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation.
Vandebriel RJ; Stalpers CAL; Vermeulen JP; Remkes M; Schmelter M; Broere F; Hoefnagel MHN
Vaccine; 2022 Sep; 40(38):5601-5607. PubMed ID: 35999078
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4- and NACHT, LRR and PYD domains-containing protein 3-independent mechanisms of alum enhanced T helper type 2 responses on basophils.
Huang FJ; Ma YL; Tang RY; Gong WC; Li J; Chen CX; Yin L; Chen XP
Immunology; 2016 Oct; 149(2):238-51. PubMed ID: 27315109
[TBL] [Abstract][Full Text] [Related]
6. Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity.
Li X; Hufnagel S; Xu H; Valdes SA; Thakkar SG; Cui Z; Celio H
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22893-22901. PubMed ID: 28621928
[TBL] [Abstract][Full Text] [Related]
7. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
Demento SL; Eisenbarth SC; Foellmer HG; Platt C; Caplan MJ; Mark Saltzman W; Mellman I; Ledizet M; Fikrig E; Flavell RA; Fahmy TM
Vaccine; 2009 May; 27(23):3013-21. PubMed ID: 19428913
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.
Iyer S; HogenEsch H; Hem SL
Vaccine; 2003 Mar; 21(11-12):1219-23. PubMed ID: 12559801
[TBL] [Abstract][Full Text] [Related]
9. Cell-Penetrating Nanoparticles Activate the Inflammasome to Enhance Antibody Production by Targeting Microtubule-Associated Protein 1-Light Chain 3 for Degradation.
Zhu M; Du L; Zhao R; Wang HY; Zhao Y; Nie G; Wang RF
ACS Nano; 2020 Mar; 14(3):3703-3717. PubMed ID: 32057231
[TBL] [Abstract][Full Text] [Related]
10. Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses.
Xu H; Ruwona TB; Thakkar SG; Chen Y; Zeng M; Cui Z
Hum Vaccin Immunother; 2017 Nov; 13(11):2688-2694. PubMed ID: 28933668
[TBL] [Abstract][Full Text] [Related]
11. [Effect of aluminium hydroxide on innate immunity and immunogenicity of bacterial and synthetic antigens of Streptococcus pneumoniae].
Kurbatova EA; Akhmatov ÉA; Akhmatova NK; Vorob'ev DS; Egorova NB; Baturo AP; Romanenko ÉE; Tsvetkov IuE; Sukhova EV; Iashunskiĭ DV; Nifant'ev NÉ
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):59-67. PubMed ID: 25816515
[TBL] [Abstract][Full Text] [Related]
12. Advances in aluminum hydroxide-based adjuvant research and its mechanism.
He P; Zou Y; Hu Z
Hum Vaccin Immunother; 2015; 11(2):477-88. PubMed ID: 25692535
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine.
Thakkar SG; Warnken ZN; Alzhrani RF; Valdes SA; Aldayel AM; Xu H; Williams RO; Cui Z
J Control Release; 2018 Dec; 292():111-118. PubMed ID: 30339906
[TBL] [Abstract][Full Text] [Related]
14. Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.
Tunheim G; Arnemo M; Naess LM; Norheim G; Garcia L; Cardoso D; Mandiarote A; Gonzalez D; Sinnadurai K; Fjeldheim ÅK; Bolstad K; Rosenqvist E
APMIS; 2016 Nov; 124(11):996-1003. PubMed ID: 27651089
[TBL] [Abstract][Full Text] [Related]
15. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
Kool M; Soullié T; van Nimwegen M; Willart MA; Muskens F; Jung S; Hoogsteden HC; Hammad H; Lambrecht BN
J Exp Med; 2008 Apr; 205(4):869-82. PubMed ID: 18362170
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
[TBL] [Abstract][Full Text] [Related]
18. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
Shirasuna K; Karasawa T; Takahashi M
J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
[TBL] [Abstract][Full Text] [Related]
19. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties.
Goto N; Kato H; Maeyama J; Shibano M; Saito T; Yamaguchi J; Yoshihara S
Vaccine; 1997; 15(12-13):1364-71. PubMed ID: 9302746
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity.
Capelle MA; Brügger P; Arvinte T
Vaccine; 2005 Feb; 23(14):1686-94. PubMed ID: 15705473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
